Belgium
Site Groupe
Guerbet Worldwide
Asia Pacific
Belgium
Brazil
France
Germany
Italy
Japan
Korea
Mexico
Turkey
United Kingdom
USA
MEDEX
SIMAFEX
Cours de l'action
109.60 €
About Us
Professional
Biomedical
Library search
Patients
Orders
Job offers
Breaking News
Updated information on NSF
USA : FDA approves Dotarem®
Guerbet at ECR2013
go to Archive
